Chemomab Therapeutics Ltd. (CMMB) Financials

CMMB Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 23.4 million 5.4 million
2023-06-30 28.8 million 6.9 million
2023-03-31 35.0 million 7.1 million
2022-12-31 43.1 million 6.8 million

CMMB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -5.1 million ?
2023-06-30 -7.5 million 639000
2023-03-31 -7.2 million 484000
2022-12-31 -5.7 million 740000

CMMB Net Income

No data available :(

CMMB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 21.4 million - -
2023-06-30 26.6 million - 141000
2023-03-31 32.7 million - 177000
2022-12-31 39.9 million - 214000

CMMB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 11.8 million
2023-06-30 11.1 million
2023-03-31 11.0 million
2022-12-31 11.4 million

CMMB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 6 3.3 million - -
2023-06-30 2000 5.0 million 3.2 million -
2023-03-31 1000 6.9 million 2.2 million -
2022-12-31 1000 5.9 million 2.7 million -

CMMB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 18938
2023-06-30 - 15818
2023-03-31 - 9.0 million
2022-12-31 - 13962

CMMB

Price: $0.73

52 week price:
0.42
1.89

Earnings Per Share: -2.94 USD

P/E Ratio: -0.20

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 37000

Market Capitalization: 10.4 million

Links: